Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. 

For more detailed descriptions of many of these topics, you can sign up to receive our weekly CWMH NEWSLETTER which comes out every Thursday.  

And don’t forget to visit ESSENTIAL READS – a curated selection of up-to-date and clinically relevant articles in women’s mental health.

Ruta Nonacs, MD PhD

SIGN UP FOR OUR NEWSLETTER

PMS AND PMDD

Early and Late Luteal Executive Function, Cognitive and Somatic Symptoms, and Emotional Regulation of Women with Premenstrual Dysphoric Disorder.

Lin PC, Ko CH, Yen JY. J Pers Med. 2022 May 18;12(5):819.

Executive function was impaired in women with PMDD during the late luteal phase. Its performance correlated positively with emotion regulation and negatively with depression. Further studies were required to elucidate the possible etiology underlying these associations.

INFERTILITY AND MENTAL HEALTH

No articles this week

PSYCHIATRIC ILLNESS DURING PREGNANCY

Development of multivariable models to predict perinatal depression before and after delivery using patient reported survey responses at weeks 4-10 of pregnancy.

Reps JM, Wilcox M, McGee BA, Leonte M, LaCross L, Wildenhaus K. BMC Pregnancy Childbirth. 2022 May 26;22(1):442.

Using a survey of 21 questions administered between weeks 4 and 10, models were generated which could predict depression during each trimester and the postparutm period.


Internet-delivered psychological interventions for reducing depressive, anxiety symptoms and fear of childbirth in pregnant women: A meta-analysis and meta-regression.

Neo HS, Tan JH, Ang WHD, Lau Y. J Psychosom Res. 2022 Jun;157:110790.

Internet-delivered psychological intervention may complement usual antenatal care in the improvement of depressive and anxiety symptoms.


A Systematic Review and Meta-analysis of Parental Depression, Antidepressant Usage, Antisocial Personality Disorder, and Stress and Anxiety as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children.

Robinson LR, Bitsko RH, O’Masta B, Holbrook JR, Ko J, Barry CM, Maher B, Cerles A, Saadeh K, MacMillan L, Mahmooth Z, Bloomfield J, Rush M, Kaminski JW. Prev Sci. 2022 May 31.

Maternal stress and anxiety, maternal prenatal stress, maternal depression, maternal postpartum depression, and paternal depression were positively associated with ADHD. In addition, parental depression was associated with symptoms of ADHD inattentive and hyperactive/impulsive subtypes.


Obsessive-compulsive and related disorder symptoms in the perinatal period: prevalence and associations with postpartum functioning.

Miller ML, Roche AI, Lemon E, O’Hara MW. Arch Womens Ment Health. 2022 May 26.

In pregnancy, 14.9% of participants endorsed clinically significant BDD symptoms and 6.2% endorsed clinically significant OCD symptoms. In the postpartum period, 11.8% endorsed clinically significant BDD symptoms and 14% endorsed clinically significant OCD symptoms. Poorer postpartum functioning was associated with elevated OCD and related symptoms during pregnancy and the postpartum.


Antidepressant and mental health care utilization in pregnant women with depression and/or anxiety: An interrupted time-series analysis.

Trinh NTH, Nordeng HME, Bandoli G, Eberhard-Gran M, Lupattelli A. J Affect Disord. 2022 Jul 1; 308:458-465.

Pregnancy was associated with reduced mental health care utilization regardless of whether antidepressant treatment was maintained during pregnancy or not. Increases in mental health care utilization were observed in the postpartum year, especially in women who interrupted treatment.

MEDICATIONS AND PREGNANCY

No articles this week

POSTPARTUM PSYCHIATRIC ILLNESS

Digital screening for postnatal depression: mixed methods proof-of-concept study.

Eisner E, Lewis S, Stockton-Powdrell C, Agass R, Whelan P, Tower C. BMC Pregnancy Childbirth. 2022 May 23;22(1):429.

Digital screening for PPD appears feasible, acceptable, valid and safe. It also benefits from being remotely delivered; the researchers enrolled all participants remotely during the first COVID-19 lockdown.


Postpartum depression: A role for psychedelics?

Jairaj C, Rucker JJ. J Psychopharmacol. 2022 May 30:2698811221093793.

The authors theorize that psychedelic assisted therapy for PPD may have a positive effect on the mother-infant dyad and warrants further examination.


Pilot Testing a Brief Partner-Inclusive Hybrid Intervention for Perinatal Mood and Anxiety Disorders.

Peifer JS, Bradley E, Taasoobshirazi G. Front Psychiatry. 2022 May 11;13:735582.

In the New Family Wellness Project (NFWP), participants engage in a hybrid in-person and teletherapy six-session intervention for new parents early in their postpartum period.


Maternal Resilience and Postpartum Depression at the Neonatal Intensive Care Unit.

Mautner E, Stern C, Avian A, Deutsch M, Fluhr H, Greimel E. Front Pediatr. 2022 May 10;10:864373.

Women have different resilience parameters. Mothers with lower resilience will benefit from social support and emotional health-promoting activities.


Disparities in postnatal depression and anxiety screening: Results from a cross sectional survey of Maternal and Child health nurses in Victoria, Australia.

Arefadib N, Cooklin A, Nicholson JM, Shafiei T. Sex Reprod Healthc. 2022 May 21; 33:100737.

In a group of Maternal and Child Health nurses, 35% routinely screened for perinatal depression more than once in the first 12 months postpartum, and 31% were able to adhere to the recommended use of psychosocial assessments as part of their screening practice. After adjusting for confounding factors, nurses practicing in communities with greater socio-economic advantage were significantly more likely to conduct psychosocial assessments (aOR 3.93, 95% CI 1.47-10.49) compared to nurses who worked in disadvantaged communities.

MEDICATIONS AND BREASTFEEDING

No articles this week

PERINATAL SUBSTANCE USE

No articles this week

MATERNAL MENTAL HEALTH AND CHILD OUTCOMES

No articles this week

MENOPAUSE AND MENTAL HEALTH

Menopausal Hormone Therapy and the Mind: The Role of Hormone Replacement in the Prevention and Treatment of Cognitive Decline, Dementia, and Cognitive Dysfunction of Depression.

Koire A, Joffe H, Buckley R. Harv Rev Psychiatry. 2022 May 26.

OTHER TOPICS IN WOMEN’S MENTAL HEALTH

No articles this week

Related Posts